XML 32 R21.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 9 - Stockholders' Equity (Tables)
6 Months Ended
Dec. 31, 2015
Notes Tables  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   
Weighted
Average,
December
31,
2015
   
Range,
December
31,
2015
   
Weighted
Average,
December
31,
2014
   
Range,
December
31,
2014
 
Volatility
    74%       74%       80%       80%  
Dividend yield
    -       -       -       -  
Risk-free interest rate
    1.75%       1.75%       0.51%       0.51%  
Expected term (years)
    5       5       2       2  
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
   
Options
   
Weighted-
Average
Exercise
Price
   
Weighted-
Average
Remaining
Contractual
Life
   
Aggregate
Intrinsic
Value
 
Outstanding at July 1, 2015
    4,413,870     $ 1.88       4.1       -  
Granted
    100,000       0.92                  
Exercised
    -       -                  
Forfeited
    -       -                  
Expired
    -       -                  
Outstanding at December 31, 2015
    4,513,870     $ 1.86       3.9     $ 36,050  
Exercisable at December 31, 2015
    4,413,870     $ 1.89       3.7     $ 22,050  
Schedule of Nonvested Share Activity [Table Text Block]
   
Options
   
Weighted Average
Grant-Date Fair
Value
 
Nonvested at July 1, 2015
    100,000     $ 0.76  
Granted
    100,000       0.59  
Vested
    (100,000 )     (0.59 )
Nonvested at December 31, 2015
    100,000     $ 0.76  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]
   
Three
months
ended
December
31,
2015
   
Three
months
ended
December
31,
2014
   
Six months
ended
December
31,
2015
   
Six months
ended
December
31,
2014
 
General and administrative:
                               
Fair value of stock bonus expensed
  $ 69,000     $ -     $ 69,000     $ -  
Change in fair value from modification of
option terms
    42,550       11,783       42,550       11,783  
Fair value of stock options expensed
    62,371       4,000       64,209       4,000  
Total
  $ 173,921     $ 15,783     $ 175,759     $ 15,783  
                                 
Research and development:
                               
Fair value of stock options expensed
  $ 11,949     $ -     $ 25,431     $ -  
Total
  $ 11,949     $ -     $ 25,431     $ -